Drreddys Laboratories | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
ANI Pharmaceuticals USD 6.02M 3.68M 2024-12
Aurora Cannabis CAD 1.29M 768K 2024-12
Bayer 703M 61M 2024-12
Canopy Growth CAD 16.77M 4.51M 2024-12
Cipla 146.4M 7.6M 2024-12
Corcept Therapeutics 6M 6M 2024-06
Drreddys Laboratories INR 817M 60M 2024-12
GlaxoSmithKline 173M 17M 2024-12
Hikma Pharmaceutical 22M 9M 2024-06
Lonza CHF 59M 6M 2024-06
Novartis USD 275M 11M 2024-12
Pacira USD 4.68M 9K 2024-12
Prestige Brands USD 11.37M 908K 2024-12
Richter Gedeon HUF 7.5B 9.53B 2024-09
Sun Pharmaceuticals 515.1M 453.56M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
Teva Pharmaceutical Industries USD 224M 1000K 2024-12



Drreddys Laboratories Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.